Abstract
In 1980 the Cancer Research Campaign launched a multi-centre breast cancer trial; aimed at repeating the Scandinavian Chemotherapy Study Group's cyclophosphamide trial, and the NATO tamoxifen study; thereby further evaluating the role of these two adjuvant regimens in patients with early breast cancer. Two thousand two hundred and thirty women were randomized into this trial between 1980 and 1985 and preliminary analyses demonstrate a significant improvement in event-free survival for both regimens. Results from this study closely parallel the two trials it set out to repeat.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Nissen-Meyer R., Kjellgren K., Malmio K., Månsson B., Norin T. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer. 1978 Jun;41(6):2088–2098. doi: 10.1002/1097-0142(197806)41:6<2088::aid-cncr2820410604>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Nissen-Meyer R., Kjellgren K., Mansson B. Adjuvant chemotherapy in breast cancer. Recent Results Cancer Res. 1982;80:142–148. doi: 10.1007/978-3-642-81685-7_24. [DOI] [PubMed] [Google Scholar]
- Ribeiro G., Palmer M. K. Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):827–830. doi: 10.1136/bmj.286.6368.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rose C., Thorpe S. M., Mouridsen H. T., Andersen J. A., Brincker H., Andersen K. W. Antiestrogen treatment of postmenopausal women with primary high risk breast cancer. Breast Cancer Res Treat. 1983;3(1):77–84. doi: 10.1007/BF01806237. [DOI] [PubMed] [Google Scholar]
- Tate H. C., Rawlinson J. B., Freedman L. S. Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet. 1979 Sep 22;2(8143):623–625. doi: 10.1016/s0140-6736(79)91676-3. [DOI] [PubMed] [Google Scholar]
- Wilson A. J., Baum M., Brinkley D. M., Dossett J. A., McPherson K., Patterson J. S., Rubens R. D., Smiddy F. G., Stoll B. A., Richards D. Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. World J Surg. 1985 Oct;9(5):756–764. doi: 10.1007/BF01655191. [DOI] [PubMed] [Google Scholar]